Skip to main content
Log in

Further evidence that acanthosis nigricans maligna is linked to enhanced secretion by the tumour of transforming growth factor alpha

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

The pathogenesis of cutaneous paraneoplastic syndromes is still under discussion. Since many of these syndromes, including acanthosis nigricans, are proliferative skin disorders it is believed that products secreted by the tumour stimulate the keratinocytes to proliferate. Growth factors like transforming growth factor alpha (TGF-alpha) are known to be highly mitogenic for keratinocytes in vitro. Here we report on a patient with a poorly differentiated gastric cancer and a full clinical picture of acanthosis nigricans characterized by diffuse hyperkeratosis and multiple papillomatous lesions of the skin with involvement of the conjunctivae. In Southern blot analysis of the tumour tissue from this patient amplification of the epidermal growth factor (EGF) receptor, the common ligand for TGF-alpha and EGF, was shown. Immunohistochemically, prominent staining was found throughout the tumour using anti-TGF-alpha antibodies. In a series of 25 investigated gastric tumour biopsies, four tumours showed amplification of the EGF receptor and one additional biopsy was positive for TGF-alpha. Since there is no other report describing the link between TGF-alpha and acanthosis nigricans, except that of Ellis et al. 1987, we present a new case suggesting a possible link between growth factors and acanthosis nigricans maligna.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brown J, Winkelmann RK (1968) Acanthosis nigricans: a study of 90 cases. Medicine 47: 33–51

    Google Scholar 

  2. Coffey RJ, Derynck R, Wilcox JN, Bringmann TS, Goustin AS, Moses HL, Pittelkow MR (1987) Production and autoinduction of transforming growth factor-alpha in human keratinocytes. Nature 328: 817–820

    Google Scholar 

  3. Curth HO (1979) Classification of acanthosis nigricans. Int J Dermatol 15: 592–593

    Google Scholar 

  4. Derynck R (1988) Transforming growth factor alpha. Cell 54: 593–595

    Google Scholar 

  5. Ellis DL, Kafka SP, Chow JC, Nanney LB, Inmann WH, McCadden ME, King LE (1987) Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat and multiple acrochordons. N Engl J Med 317: 1582–1587

    Google Scholar 

  6. Falco JP, Baylin SB, Lupu R, Borges M, Nelkin BD, Jasti RK, Davidson NE, Mabry M (1990) v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in small cell lung cancer cell line. J Clin Invest 85: 1740–1745

    Google Scholar 

  7. Gheerart P, Goens J, Schwartz RA, Lambert WC, Schroeder F, Debusscher L (1991) Florid cutaneous papillomatosis, malignant acanthosis nigricans, and pulmonary squamous cell carcinoma. Int J Dermatol 30: 193–197

    Google Scholar 

  8. Gottlieb AB, Chang CK, Posnet DN, Fanelli B, Tam JP (1988) Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med 167: 670–675

    Google Scholar 

  9. Gross G, Pfister H, Hellenthal B, Hagedorn M (1984) Acanthosis nigricans maligna. Dermatologica 168: 265–272

    Google Scholar 

  10. Hage E, Hage J (1977) Malignant acanthosis nigricans: a para-endocrine syndrome. Acta Derm Venereol (Stockh) 57: 169–172

    Google Scholar 

  11. Janier M, Blanchet-Bardon C, Bonvalet D, Lenoble M, Boiget F, Civatte J (1988) Three malignant acanthosis nigricans associated with non-Hodgkin's lymphoma. Report on two cases. Dermatologica 176: 133–137

    Google Scholar 

  12. Janovsky V (1890) Acanthosis nigricans. In: Unna PG, Morris M, Besnier E, et al (eds) International atlas of rare skin diseases (part 4). HK Lewis, London, p 1

    Google Scholar 

  13. King LE, Gates RE, Stoschek CM, Nanney LB (1990) The EGF/TGF-alpha receptor in skin. J Invest Dermatol 94: 164–170

    Google Scholar 

  14. Mikhail GR, Fachnie DM, Drukker BH, Farah R, Allen HM (1979) Generalized malignant acanthosis nigricans. Arch Dermatol 115: 201–202

    Google Scholar 

  15. Nanney LB, Ellis DL, Dale B, Stoscheck CM, Holbrook KA, King LE (1988) Epidermal growth factor receptors in idiopathic and virally induced hyperproliferative skin diseases. Clin Res 36: 678A

    Google Scholar 

  16. Nomachi K, Mori M, Matsuda N (1989) Improvement of oral lesions associated with malignant acanthosis nigricans after treatment of lung cancer. Oral Surg Oral Med Oral Pathol 68: 74–79

    Google Scholar 

  17. Pollitzer S (1890) Acanthosis nigricans. In: Unna PG, Morris M, Besnier E et al (eds) International atlas of rare skin diseases (part 4). HK Lewis, London, p 6

    Google Scholar 

  18. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418–423

    Google Scholar 

  19. Yoshida K, Yasui W, Ito H, Tahare E (1990) Growth factors in progression of human esophageal and gastric carcinomas. Exp Pathol 40: 291–300

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilgenbus, K., Lentner, A., Kuckelkorn, R. et al. Further evidence that acanthosis nigricans maligna is linked to enhanced secretion by the tumour of transforming growth factor alpha. Arch Dermatol Res 284, 266–270 (1992). https://doi.org/10.1007/BF00372579

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00372579

Key words

Navigation